Evaluation of Patellar Crepitus Following Total Knee Arthroplasty
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT01340144 |
|
Recruitment Status :
Completed
First Posted : April 22, 2011
Results First Posted : March 5, 2015
Last Update Posted : March 25, 2015
|
- Study Details
- Tabular View
- Study Results
- Disclaimer
- How to Read a Study Record
| Condition or disease |
|---|
| Total Knee Replacement |
| Study Type : | Observational |
| Actual Enrollment : | 1250 participants |
| Observational Model: | Case-Control |
| Time Perspective: | Prospective |
| Official Title: | Evaluation of Patellar Crepitus Following PFC Sigma vs. PFC Sigma HP Total Knee Arthroplasty: Does Femoral Component Design Make a Difference? |
| Study Start Date : | April 2011 |
| Actual Primary Completion Date : | June 2014 |
| Actual Study Completion Date : | September 2014 |
| Group/Cohort |
|---|
|
PFC Sigma PS TKA
one group received primary TKA using the PFC Sigma PS TKA
|
|
PFC Sigma HP PS TKA
One group received primary TKA using the PFC Sigma HP PS TKA.
|
- Evaluate for the Incidence of Patellar Crepitus Requiring Non-operative vs. Operative Treatment of Both the Study and Control Groups at a Minimum of 12 Months Following the TKA (Total Knee Arthroplasty) Procedure in Each Subject. [ Time Frame: Two years after TKA (Total Knee Arthroplasty) procedure ]The incidence of patellar crepitus and clunk will be statistically compared between the study (PFC Sigma HP PS TKA) and control (PFC Sigma PS TKA groups). Based on a strength analysis to determine a theoretical reduction in the incidence of patellar crepitus from 5% to 2%, a study group of 625 subjects in both the control and study ggroups will be required. Each group will also be statistically analyzed using the following variables: overall crepitus incidence, incidence of crepitus requiring only non-operative treatment vs. those requiring operative treatment to manage this complication.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | Child, Adult, Older Adult |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Probability Sample |
Inclusion Criteria:
- subjects that received primary total knee replacement
Exclusion Criteria:
- Did not return for follow - up appointments Required any post operative manipulation
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01340144
| Principal Investigator: | Raymond Kim, MD | Porter Adventist Hospital |
| Responsible Party: | Colorado Joint Replacement |
| ClinicalTrials.gov Identifier: | NCT01340144 |
| Other Study ID Numbers: |
IIS-000112 |
| First Posted: | April 22, 2011 Key Record Dates |
| Results First Posted: | March 5, 2015 |
| Last Update Posted: | March 25, 2015 |
| Last Verified: | March 2015 |
|
total knee replacement patellar crepitus Replacement of knee joint |

